Gardasil
Showing 1 - 25 of 173
Vaccine Reaction Trial in Bandung (Gardasil, PharmaJet Stratis® Needle-Free Injection System, PharmaJet Tropis® Needle-Free
Not yet recruiting
- Vaccine Reaction
- Gardasil
- +2 more
-
Bandung, IndonesiaUniversitas Padjadjaran
Nov 16, 2023
HPV Infection Trial in Boston (Gardasil 9 2 dose regimen, Gardasil 9 3 dose regimen, Gardasil 9 rescue dose)
Recruiting
- HPV Infection
- Gardasil 9 2 dose regimen
- +2 more
-
Boston, MassachusettsBoston Medical Center
Dec 16, 2022
Immunization, Efficacy, Human Papilloma Virus Trial in Galveston (9-valent HPV vaccine, 2 dose efficacy, 9-valent HPV vaccine, 3
Recruiting
- Immunization
- +2 more
- 9-valent HPV vaccine, 2 dose efficacy
- 9-valent HPV vaccine, 3 doses standard timing
-
Galveston, TexasUniversity of Texas Medical Branch
Jan 30, 2023
Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell Tumor Trial in Houston (Recombinant
Active, not recruiting
- Allogeneic Hematopoietic Stem Cell Transplant Recipient
- Hematopoietic and Lymphoid Cell Neoplasm
- Recombinant Human Papillomavirus Nonavalent Vaccine
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Cervical Cancer, Genital Wart, CIN Trial in Nanning (Zerun HPV-9, GARDASIL ®9)
Active, not recruiting
- Cervical Cancer
- +4 more
- Zerun HPV-9
- GARDASIL ®9
-
Nanning, Guangxi, ChinaGuangXi Center for Diseases Control and Prevention
Oct 26, 2022
Human Papilloma Virus, Anogenital Wart Trial in Zagazig (the Quadrivalent Vaccine (Gardasil))
Recruiting
- Human Papilloma Virus
- Anogenital Wart
- the Quadrivalent Vaccine (Gardasil)
-
Zagazig, EgyptRana Ehab
Feb 26, 2023
Immunogenicity of HPV Vaccine in Transplant Recipients.
Not yet recruiting
- Chronic Kidney Diseases
- Kidney Transplant
- Human Papilloma Virus vaccine (GARDASIL 9)
-
Milwaukee, WisconsinFroedtert Lutheran Memorial Hospital
Sep 22, 2022
Dengue Fever, Dengue Hemorrhagic Fever, Human Papillomavirus Disease Trial in Malaysia (CYD Dengue Vaccine, Human Papillomavirus
Completed
- Dengue Fever
- +2 more
- CYD Dengue Vaccine
- Human Papillomavirus Quadrivalent [Types 6, 11, 16, and 18] Vaccine, Recombinant.
-
Klang, Malaysia
- +4 more
Mar 15, 2022
Vulvar HSIL, HPV Trial in Rotterdam (Gardasil 9 Suspension for Injection, Placebo)
Not yet recruiting
- Vulvar HSIL
- HPV
- Gardasil 9 Suspension for Injection
- Placebo
-
Rotterdam, NetherlandsErasmus MC
Sep 21, 2023
Warts Trial in Salt Lake City (Human Papillomavirus 9-valent Vaccine, Recombinant, Normal Saline)
Not yet recruiting
- Warts
- Human Papillomavirus 9-valent Vaccine, Recombinant
- Normal Saline
-
Salt Lake City, Utah
- +1 more
Nov 23, 2022
Papillomavirus Vaccines, Human Immunodeficiency Virus, Papillomavirus Infection Trial in New Orleans (Human papillomavirus
Not yet recruiting
- Papillomavirus Vaccines
- +6 more
- Human papillomavirus 9-valent vaccine, recombinant
-
New Orleans, LouisianaUniversity Medical Center New Orleans
Mar 3, 2022
Cervical Cancer, Genital Warts Trial (Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine, Matching Placebo)
Active, not recruiting
- Cervical Cancer
- Genital Warts
- Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine
- Matching Placebo
- (no location specified)
Aug 22, 2022
Human Papillomavirus Infection Trial in Guangzhou, Nanjing, Taiyuan (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58)
Active, not recruiting
- Human Papillomavirus Infection
- Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
- Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)（GARDASIL®）
-
Guangzhou, Guangdong, China
- +2 more
Dec 30, 2022
HPV Infection Trial in H?i Phòng (Gardasil®, Merck)
Active, not recruiting
- HPV Infection
- Gardasil®, Merck
-
Hải Phòng, VietnamHai Phong District Health Centre
Sep 20, 2022
Human Papillomavirus Vaccine Trial in Banjul (9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses, 9-valent human
Active, not recruiting
- Human Papillomavirus Vaccine
- 9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses
- +2 more
-
Banjul, Outside U.S. And Canada, GambiaEd Clarke
Mar 15, 2022
Cervical Cancer, Condylomata Acuminata Trial in Nanjing (Recombinant Human Papillomavirus Nonavalent (Types
Active, not recruiting
- Cervical Cancer
- Condylomata Acuminata
- Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58 )Vaccine(E.Coli)
- Gardasil®9
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Centre for Disease Control and Prevention
Feb 10, 2022
Idiopathic CD4 T Cell Lymphocytopenia Trial run by the NIAID (Gardasil 9)
Recruiting
- Idiopathic CD4 T Cell Lymphocytopenia
- Gardasil 9
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 10, 2023
Verruca Viral Trial in Zagazig (Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine, Bivalent Human
Completed
- Verruca Viral
- Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine
- +2 more
-
Zagazig, Select Region, EgyptDermatology department, Zagazig University Hospitals, Faculty of
May 17, 2022
Human Papillomavirus-Related Carcinoma Trial in Austria, United States (procedure, biological, other)
Not yet recruiting
- Human Papillomavirus-Related Carcinoma
- Biospecimen Collection
- +4 more
-
Birmingham, Alabama
- +4 more
Aug 9, 2023
Human Papillomavirus Infection Trial in Montreal (HPV vaccine, Gardasil 9, Hepatitis A vaccine)
Active, not recruiting
- Human Papillomavirus Infection
- HPV vaccine, Gardasil 9
- Hepatitis A vaccine
-
Montreal, Quebec, CanadaMcGill University - Division of Cancer Epidemiology
Oct 20, 2022
HPV, Human Papilloma Virus, Human Immunodeficiency Virus Trial in Vancouver (Nonavalent HPV vaccine)
Not yet recruiting
- HPV
- +2 more
- Nonavalent HPV vaccine
-
Vancouver, British Columbia, CanadaUniversity of British Columbia
Aug 8, 2022
Papillomavirus Infections Trial in Quzhou, Taizhou (9vHPV vaccine)
Active, not recruiting
- Papillomavirus Infections
- 9vHPV vaccine
-
Quzhou, Zhejiang, China
- +1 more
Sep 1, 2022